Financhill
Sell
49

ORKA Quote, Financials, Valuation and Earnings

Last price:
$33.00
Seasonality move :
-7.41%
Day range:
$32.42 - $34.38
52-week range:
$5.49 - $34.38
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.32x
Volume:
451.5K
Avg. volume:
632.4K
1-year change:
171.27%
Market cap:
$1.6B
Revenue:
--
EPS (TTM):
-$2.42

Earnings Data

Next earnings date for ORKA
Mar 05
2026
Most recent earnings per share
-$0.69
Missed by $0.16
(Nov 12/2025)
Consensus Estimate
-$0.52
(Nov 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ORKA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 -- -- -- -$0.62 --
03/05/2026 Q4 -- -- -- -$0.62 --
11/12/2025 Q3 -- -- -$0.69 -$0.52 -$0.16
08/11/2025 Q2 -- -- -$0.58 -$0.43 -$0.15
05/14/2025 Q1 -- -- -$0.50 -$0.48 -$0.03
03/06/2025 Q4 -- -- -$0.64 -$0.98 $0.34
11/13/2024 Q3 -- -- -$1.91 -$0.32 -$1.58
06/30/2024 Q2 -- -- -$6.96 -- --
03/31/2024 Q1 -- -- -$318.67 -- --
12/31/2023 Q4 -- -- -$0.90 -- --
09/30/2023 Q3 -- -- -$1.19 -- --
06/30/2023 Q2 -- -- -$1.23 -- --
03/31/2023 Q1 -- -- -$1.12 -- --
12/31/2022 Q4 -- -- -$0.98 -- --
09/30/2022 Q3 -- -- -$1.94 -- --
06/30/2022 Q2 -- -- -$2.62 -- --
03/31/2022 Q1 -- -- -$2.72 -- --
12/31/2021 Q4 -- -- -$4.73 -- --
09/30/2021 Q3 -- -- -$3.92 -- --
06/30/2021 Q2 -- -- -$4.03 -- --
03/31/2021 Q1 -- -- -$3.98 -- --
12/31/2020 Q4 -- -- -$6.44 -- --
09/30/2020 Q3 -- -- -$3.95 -- --
06/30/2020 Q2 -- -- -$8.71 -- --
03/31/2020 Q1 -- -- -$9.94 -- --
12/31/2019 Q4 -- -- -$9.23 -- --
09/30/2019 Q3 -- -- -$9.12 -- --
06/30/2019 Q2 -- -- -$13.64 -- --
03/31/2019 Q1 -- -- -$22.29 -- --
12/31/2018 Q4 -- -- -$23.10 -- --
09/30/2018 Q3 -- -- -$24.71 -- --
06/30/2018 Q2 -- -- -$32.83 -- --
03/31/2018 Q1 -- -- -$43.37 -- --
12/31/2017 Q4 -- -- -$76.99 -- --
09/30/2017 Q3 -- -- -$83.24 -- --
06/30/2017 Q2 -- -- -$127.91 -- --
03/31/2017 Q1 -- -- -$103.03 -- --
12/31/2016 Q4 -- -- -$100.93 -- --
09/30/2016 Q3 -- -- -$110.16 -- --
06/30/2016 Q2 -- -- -$92.88 -- --
03/31/2016 Q1 -- -- -$86.40 -- --

Oruka Therapeutics, Inc. Earnings Questions

  • How Much did Oruka Therapeutics, Inc. Generate in Revenue Last Quarter?

    Oruka Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Oruka Therapeutics, Inc. Beat Earnings Last Quarter?

    Oruka Therapeutics, Inc. announced earnings per share of -$0.69 which represents a miss of analyst forecast a -$0.52 per share.

  • Is Oruka Therapeutics, Inc. Profitable?

    Oruka Therapeutics, Inc. reported -$20K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Oruka Therapeutics, Inc. EPS Next Year?

    Oruka Therapeutics, Inc.'s earnings are forecast to decrease from -$4.99 per share to -$2.06 per share next year representing a decrease of -52.07%.

  • When is Oruka Therapeutics, Inc.'s Earnings Date?

    Oruka Therapeutics, Inc.'s next earnings date is March 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Goldman Sachs Going to Go Up?
Is Goldman Sachs Going to Go Up?

Shares of financial giant Goldman Sachs (NYSE:GS) have soared by…

How High Will MSTR Stock Go?
How High Will MSTR Stock Go?

After several months of pressure, shares of Bitcoin treasury Strategy…

Is Progressive a Good Stock to Own?
Is Progressive a Good Stock to Own?

After faring well for multiple years, shares of property and…

Stock Ideas

Sell
49
Is NVDA Stock a Buy?

Market Cap: $4.3T
P/E Ratio: 61x

Buy
53
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Sell
42
Is GOOGL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
70
RAPT alert for Jan 21

Rapt Therapeutics, Inc. [RAPT] is up 0.07% over the past day.

Buy
73
HYMC alert for Jan 21

Hycroft Mining Holding Corp. [HYMC] is down 6.64% over the past day.

Buy
92
GMINF alert for Jan 21

G Mining Ventures Corp. [GMINF] is down 1.85% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock